The strongest reduction in term of growth and survival for cancer cells was observed for MK2206 Akt inhibitor.45 Recently, Bajrami et al46 identified a synthetic lethal interaction between E‐cad and ROS1. ROS1 gene rearrangements represent well‐known cancer‐related aberrations and therapeutic targets of approved drugs. This evidence concerns the gene AKT1 and cancer.